Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07763418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Name: A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function — clinical trial record (NCT07763418)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorBristol-Myers Squibb

Started2026-09-08

View on ClinicalTrials.gov ↗

Amendment history

2026-10-02

Recruitment opened

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

Chronic Kidney Disease

1,314 trials monitored

See 54 trials at risk

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.

Trial Details

NCT Number	NCT07763418
Lead Sponsor	Bristol-Myers Squibb
Conditions	Kidney Failure, Chronic
Enrollment	30 participants
Start Date	2026-09-08
Primary Completion	2026-12-14 (estimated)
Study Completion	2026-12-28 (estimated)
Updated on ClinicalTrials.gov	2026-10-01